|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Mr. Michael Singer||Exec. Chairman & Interim CEO||N/D||N/D||1965|
|Mr. Glen Ibbott||Chief Financial Officer||N/D||N/D||N/D|
|Mr. Allan John Cleiren C.P.A., C.A., ICD.D.||Chief Operating Officer||N/D||N/D||N/D|
|Mr. Darryl Vleeming||Chief Information Officer||N/D||N/D||N/D|
|Dr. Jonathan Page Ph.D.||Chief Science Officer||N/D||N/D||1969|
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topicals kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
L'ISS Governance QualityScore di Aurora Cannabis Inc. al 8 dicembre 2019 è 10. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 10; diritti degli azionisti: 10; retribuzione: 7.